| For: | Shen R, Feng JH, Yang SP. Acromicric dysplasia caused by a mutation of fibrillin 1 in a family: A case report. World J Clin Cases 2023; 11(9): 2036-2042 [PMID: 36998968 DOI: 10.12998/wjcc.v11.i9.2036] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i9/2036.htm |
| Number | Citing Articles |
| 1 |
Ray Thomas Katbe, Laure Boutsen, Philippe A. Lysy. Geleophysic Dysplasia Associated With FBN1 Mutation: Clinical Course, Valvular Heart Disease, and Response to Recombinant Human Growth Hormone Therapy. Clinical Case Reports 2026; 14(4) doi: 10.1002/ccr3.71957
|
| 2 |
Fengyan Tian, Xiao Dong, Ruyue Yuan, Xiaohan Hou, Jing Qing, Yani Li. Case Report: Two different acromelic dysplasia phenotypes in a Chinese family caused by a missense mutation in FBN1 and a literature review. Frontiers in Pediatrics 2024; 12 doi: 10.3389/fped.2024.1428513
|
| 3 |
Jun Zhang, Meng-Tian Huang, Bing Wang, Yan-Yan Lin, Ru-Jiang Zheng, Huang-Meng Xiao, Hua-Mei Ma, Song Guo, Qiu-Li Chen, Yan-Hong Li. FBN1 TB5 domain variants in acromelic dysplasia: multisystem manifestations, genotype–phenotype correlations, and partial responses to growth hormone therapy. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1883383
|